API reference

ERLOTINIB HCl

CAS number
183319-69-9
Molecular formula
C22H24ClN3O4
Molecular weight
429.9 g/mol
ERLOTINIB HCl — 2D structure
2D structure (PubChem)

About this molecule

Erlotinib Hydrochloride is the hydrochloride salt of a quinazoline derivative with antineoplastic properties. Competing with adenosine triphosphate, erlotinib reversibly binds to the intracellular catalytic domain of epidermal growth factor receptor (EGFR) tyrosine kinase, thereby reversibly inhibiting EGFR phosphorylation and blocking the signal transduction events and tumorigenic effects associated with EGFR activation.

Source: NCI Thesaurus (NCIt), via PubChem.

Identifiers

IUPAC name
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride
InChIKey
GTTBEUCJPZQMDZ-UHFFFAOYSA-N
SMILES
COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl
PubChem CID
176871

Also known as

Erlotinib hydrochloride · erlotinib HCl · Tarceva · OSI-774 · OSI 774 · HCl, Erlotinib · 11C erlotinib · CP-358,774-01

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com